Descubre y comparte nuestro conocimiento público

Se han encontrado 1.534 recursos

Resultados de búsqueda

World Health Organization[Pour une réglementation efficace des médicaments : que peut faire un pays? : document de fond, Genève 16-19 mars 1999]

Westermark, MWorld Health Organization. Division of Drug Management and PoliciesWHO Collaborating Centre for Chemical Reference Substances[WHO Collaborating Centre for Chemical Reference Substances : report on the work in 1998 / by M. Westermark]

World Health Organization[WHO Informal Consultation on Clinical Neurological Investigations Required for Patients Treated with Artemisinin Compounds and Derivatives : report of an informal consultation convened by WHO, Geneva, 20 July 1998]

Annual Meeting of National Centres Participating in the WHO International Drug Monitoring Programme (18th: 1995: Bangkok, Thailand)World Health Organization. Drug Safety Unit[Report of the eighteenth Annual Meeting of National Centres Participating in the WHO International Drug Monitoring Programme, Bangkok, Thailand, 4-7 December 1995]

Annual Meeting of National Centres Participating in the WHO International Drug Monitoring Programme (19th: 1996: Lisbon, Portugal)World Health Organization. Drug Safety Unit[Report of the nineteenth Annual Meeting of National Centres Participating in the WHO International Drug Monitoring Programme, Lisbon, Portugal, 15-18 September 1996]

Chaloner-Larsson, GillianWorld Health Organization. Vaccine Supply and Quality Unit . Global Training Network[Guide pour l' inspection des fabricants de produits biologiques / elaboré par Gillian Chaloner-Larsson]

WHO Action Programme on Essential Drugs[Monitoring and evaluating national drug policies and measuring the effects of DAP's work : theme paper for discussion]

WHO Action Programme on Essential Drugs[Suivi et évaluation des politiques pharmaceutiques nationales et mesure des effets du travail de DAP : thème de discussions approfondies]

WHO Action Programme on Essential DrugsWorld Trade Organization[Globalization and access to drugs : implications of the WTO/TRIPS Agreement]

Selecciona los documentos para visualizarlos

Nombre del archivo Ver recurso